10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,775,000 | +0.2% | 92,476 | -2.1% | 0.01% | 0.0% |
| Q3 2021 | $13,750,000 | -78.7% | 94,450 | -71.3% | 0.01% | -79.1% |
| Q2 2021 | $64,546,000 | -13.0% | 329,620 | -19.6% | 0.04% | -20.4% |
| Q1 2021 | $74,213,000 | +17.9% | 410,018 | -7.8% | 0.05% | +20.0% |
| Q4 2020 | $62,957,000 | +43.8% | 444,609 | +26.6% | 0.04% | +28.6% |
| Q3 2020 | $43,770,000 | +49.6% | 351,055 | +7.2% | 0.04% | +34.6% |
| Q2 2020 | $29,250,000 | – | 327,512 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |